Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
109.04 (1y: +27%)
Market Cap 5.18 B P/E(ttm) 20.10
Enterprise Value 5.57 B P/B 2.40
COO- NYSE (USA)
Cooper Companies
  • Currently 2.5/5
Business Predictability Rank: 2.5-Star
Back Testing Results:
Average gain of all 2.5-Star stocks: 7.3% per year.
% of Stocks that are in still loss if held for 10yrs: 18%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$109.04
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry		 vs
history
Cash to Debt 0.034
COO's Cash to Debt is ranked lower than
628930% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.63 vs. COO: 0.034 )
COO' s 10-Year Cash to Debt Range
Min: 0   Max: 0.34
Current: 0.03
0
0.34
Equity to Asset 0.207
COO's Equity to Asset is ranked lower than
699300% of the 143 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.56 vs. COO: 0.207 )
COO' s 10-Year Equity to Asset Range
Min: -0.02   Max: 0.29
Current: 0.21
-0.02
0.29
Interest Coverage 24.1
COO's Interest Coverage is ranked lower than
877192% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 73.90 vs. COO: 24.1 )
COO' s 10-Year Interest Coverage Range
Min: 1   Max: 24
Current: 24.1
1
24
F-Score: 8
Z-Score: 5.73
M-Score: -2.36
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry		 vs
history
Operating margin (%) 19.60
COO's Operating margin (%) is ranked lower than
892856% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 13.00 vs. COO: 19.60 )
COO' s 10-Year Operating margin (%) Range
Min: 4.8   Max: 23.8
Current: 19.6
4.8
23.8
Net-margin (%) 17.2
COO's Net-margin (%) is ranked lower than
980391% of the 102 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.20 vs. COO: 17.2 )
COO' s 10-Year Net-margin (%) Range
Min: -1.2   Max: 18.9
Current: 17.2
-1.2
18.9
ROE (%) 11.3
COO's ROE (%) is ranked lower than
990098% of the 101 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.30 vs. COO: 11.3 )
COO' s 10-Year ROE (%) Range
Min: -0.8   Max: 17.1
Current: 11.3
-0.8
17.1
ROA (%) 8.4
COO's ROA (%) is ranked lower than
980391% of the 102 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.30 vs. COO: 8.4 )
COO' s 10-Year ROA (%) Range
Min: -0.4   Max: 11.4
Current: 8.4
-0.4
11.4
ROC (Joel Greenblatt) (%) 27.00
COO's ROC (Joel Greenblatt) (%) is ranked lower than
900900% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.40 vs. COO: 27.00 )
COO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 5.2   Max: 52.8
Current: 27
5.2
52.8
Revenue Growth (%) 5.5
COO's Revenue Growth (%) is ranked lower than
1176469% of the 85 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.60 vs. COO: 5.5 )
COO' s 10-Year Revenue Growth (%) Range
Min: 4   Max: 17
Current: 5.5
4
17
EBITDA Growth (%) 10.8
COO's EBITDA Growth (%) is ranked lower than
1587300% of the 63 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.70 vs. COO: 10.8 )
COO' s 10-Year EBITDA Growth (%) Range
Min: -5.2   Max: 20.2
Current: 10.8
-5.2
20.2
EPS Growth (%) 22.9
COO's EPS Growth (%) is ranked lower than
1923075% of the 52 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 14.30 vs. COO: 22.9 )
COO' s 10-Year EPS Growth (%) Range
Min: -9.3   Max: 26.2
Current: 22.9
-9.3
26.2
ยป COO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

COO Guru Trades in Q2 2012

Ken Fisher 17,012 sh (New)
Steve Mandel 2,017,657 sh (New)
Paul Tudor Jones Sold Out
Steven Cohen 232,126 sh (-1.63%)
Mario Gabelli 65,000 sh (-13.91%)
Jim Simons 104,100 sh (-66.34%)
» More
Q3 2012

COO Guru Trades in Q3 2012

Ray Dalio 14,658 sh (New)
Paul Tudor Jones 3,500 sh (New)
Steve Mandel Sold Out
Ken Fisher 17,000 sh (-0.07%)
Mario Gabelli 54,000 sh (-16.92%)
Steven Cohen 110,400 sh (-52.44%)
Jim Simons 22,500 sh (-78.39%)
» More
Q4 2012

COO Guru Trades in Q4 2012

Jim Simons 398,598 sh (+1671.55%)
Steven Cohen 277,530 sh (+151.39%)
Ken Fisher 41,300 sh (+142.94%)
Paul Tudor Jones Sold Out
Ray Dalio Sold Out
Mario Gabelli 44,000 sh (-18.52%)
» More
Q1 2013

COO Guru Trades in Q1 2013

Paul Tudor Jones 4,500 sh (New)
Manning & Napier Advisors, Inc 126,040 sh (New)
Bruce Kovner 55,000 sh (New)
Ken Fisher 55,000 sh (+33.17%)
Mario Gabelli 42,000 sh (-4.55%)
Jim Simons 349,898 sh (-12.22%)
Steven Cohen 127,503 sh (-54.06%)
» More
» Details

Insider Trades

Latest Guru Trades with COO

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ray Dalio 2012-12-31 Sold Out 0.02%$89.4 - $100.67 $ 109.0414%0
Steve Mandel 2012-09-30 Sold Out 0.95%$72.45 - $94.83 $ 109.0433%0
Ray Dalio 2012-09-30 New Buy0.02%$72.45 - $94.83 $ 109.0433%14658
Steve Mandel 2012-06-30 New Buy0.95%$76.63 - $88.45 $ 109.0431%2017657
Richard Perry 2012-03-31 Sold Out 0.44%$68.74 - $81.96 $ 109.0456%0
Joel Greenblatt 2012-03-31 Sold Out 0.04%$68.74 - $81.96 $ 109.0456%0
Mario Gabelli 2012-03-31 Reduce -25.25%0.01%$68.74 - $81.96 $ 109.0456%75500
Richard Perry 2011-12-31 New Buy0.44%$56.64 - $78.59 $ 109.0462%100000
Ray Dalio 2011-12-31 Sold Out 0.13%$56.64 - $78.59 $ 109.0462%0
Joel Greenblatt 2011-12-31 New Buy0.04%$56.64 - $78.59 $ 109.0462%4189
Ray Dalio 2011-09-30 Add 38.62%0.04%$63.8 - $83 $ 109.0444%108244
Joel Greenblatt 2011-06-30 Sold Out 0.18%$69.16 - $77.5 $ 109.0448%0
John Paulson 2011-06-30 Sold Out 0.05%$69.16 - $77.5 $ 109.0448%0
Joel Greenblatt 2011-03-31 Add 41.46%0.05%$56.06 - $70.56 $ 109.0476%8830
John Paulson 2011-03-31 New Buy0.05%$56.06 - $70.56 $ 109.0476%250600
Mario Gabelli 2011-03-31 Reduce -36.28%0.04%$56.06 - $70.56 $ 109.0476%137000
George Soros 2011-03-31 Sold Out $56.06 - $70.56 $ 109.0476%0
Joel Greenblatt 2010-12-31 New Buy0.12%$46.68 - $58.53 $ 109.04108%6242
David Dreman 2010-12-31 Sold Out 0.07%$46.68 - $58.53 $ 109.04108%0
George Soros 2010-12-31 New Buy0.01%$46.68 - $58.53 $ 109.04108%7300
Mario Gabelli 2010-06-30 Add 72%0.02%$34.85 - $41.57 $ 109.04187%215000
George Soros 2010-06-30 Sold Out 0.01%$34.85 - $41.57 $ 109.04187%0
George Soros 2010-03-31 New Buy0.01%$35.15 - $41.01 $ 109.04185%10000
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/E(ttm) 20.10
COO's P/E(ttm) is ranked lower than
934579% of the 107 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.90 vs. COO: 20.10 )
COO' s 10-Year P/E(ttm) Range
Min: 8.06   Max: 1011.75
Current: 20.1
8.06
1011.75
P/B 2.40
COO's P/B is ranked lower than
657894% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.50 vs. COO: 2.40 )
COO' s 10-Year P/B Range
Min: 0.37   Max: 6.1
Current: 2.4
0.37
6.1
P/S 3.59
COO's P/S is ranked lower than
628930% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.30 vs. COO: 3.59 )
COO' s 10-Year P/S Range
Min: 0.5   Max: 5.96
Current: 3.59
0.5
5.96
PFCF 25.36
COO's PFCF is ranked lower than
1063829% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.70 vs. COO: 25.36 )
COO' s 10-Year PFCF Range
Min: 7.34   Max: 342.65
Current: 25.36
7.34
342.65
EV-to-EBIT 19.17
COO's EV-to-EBIT is ranked lower than
704225% of the 142 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.73 vs. COO: 19.17 )
COO' s 10-Year EV-to-EBIT Range
Min: 8.3   Max: 68.2
Current: 19.17
8.3
68.2
PEG 1.32
COO's PEG is ranked lower than
1694914% of the 59 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. COO: 1.32 )
COO' s 10-Year PEG Range
Min: 0.71   Max: 296.7
Current: 1.32
0.71
296.7
Shiller P/E 39.43
COO's Shiller P/E is ranked lower than
100% of the Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: vs. COO: 39.43 )
COO' s 10-Year Shiller P/E Range
Min: 6.62   Max: 48.8
Current: 39.43
6.62
48.8

Dividend & Buy Back

vs
industry		 vs
history
Dividend Yield 0.06
COO's Dividend Yield is ranked lower than
1388888% of the 72 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.53 vs. COO: 0.06 )
COO' s 10-Year Dividend Yield Range
Min: 0.05   Max: 0.52
Current: 0.06
0.05
0.52
Yield on cost (5-Year) 0.10
COO's Yield on cost (5-Year) is ranked lower than
1369862% of the 73 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.53 vs. COO: 0.10 )
COO' s 10-Year Yield on cost (5-Year) Range
Min: 0.05   Max: 0.52
Current: 0.1
0.05
0.52
Share Buyback Rate -2
COO's Share Buyback Rate is ranked lower than
3124997% of the 32 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. COO: -2 )
COO' s 10-Year Share Buyback Rate Range
Min: 1.1   Max: -10.2
Current: -2

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 16.4
COO's Price/Net Current Asset Value is ranked lower than
684931% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.00 vs. COO: 16.4 )
COO' s 10-Year Price/Net Current Asset Value Range
Min: 3.3   Max: 21.1
Current: 16.4
3.3
21.1
Price/Tangible Book 8.7
COO's Price/Tangible Book is ranked lower than
704225% of the 142 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.60 vs. COO: 8.7 )
COO' s 10-Year Price/Tangible Book Range
Min: 5.9   Max: 192.1
Current: 8.7
5.9
192.1
Price/DCF (Projected) 1.6
COO's Price/DCF (Projected) is ranked lower than
1538460% of the 65 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.50 vs. COO: 1.6 )
COO' s 10-Year Price/DCF (Projected) Range
Min: 0.5   Max: 3.7
Current: 1.6
0.5
3.7
Price/Median PS Value 1.3
COO's Price/Median PS Value is ranked lower than
649350% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. COO: 1.3 )
COO' s 10-Year Price/Median PS Value Range
Min: 0.3   Max: 1.9
Current: 1.3
0.3
1.9
Price/Peter Lynch Fair Value 1.1
COO's Price/Peter Lynch Fair Value is ranked lower than
3124997% of the 32 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.70 vs. COO: 1.1 )
COO' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1   Max: 1.9
Current: 1.1
1
1.9
Price/Graham Number 2.9
COO's Price/Graham Number is ranked lower than
1041666% of the 96 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. COO: 2.9 )
COO' s 10-Year Price/Graham Number Range
Min: 2.1   Max: 18.8
Current: 2.9
2.1
18.8
Earnings Yield (Greenblatt) 5.20
COO's Earnings Yield (Greenblatt) is ranked lower than
799999% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. COO: 5.20 )
COO' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.5   Max: 12.1
Current: 5.2
1.5
12.1
Forward Rate of Return (Yacktman) 18.66
COO's Forward Rate of Return (Yacktman) is ranked lower than
1960782% of the 51 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 13.37 vs. COO: 18.66 )
COO' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -0.3   Max: 31.7
Current: 18.66
-0.3
31.7

Business Description

Cooper Companies, Inc. is a Delaware corporation organized in 1980. It develops, manufactures and markets healthcare products, primarily medical devices through its two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CVI develops, manufactures and markets a broad range of contact lenses for the worldwide vision correction market. CVI is a manufacturer of toric lenses, which correct astigmatism, multifocal lenses for presbyopia (blurring near vision due to advancing age) and spherical lenses that correct the most common visual defects. CVI offers spherical, aspherical, toric, multifocal and toric multifocal lens products in all primary modalities. CSI develops, manufactures and markets medical devices, diagnostic products and surgical instruments and accessories used primarily by gynecologists and obstetricians. CSI's products are primarily manufactured and distributed at its facilities in Trumbull, Connecticut, Stafford, Texas, and Pasadena, California. CSI focuses on selected segments of the women's healthcare market, supplying high quality diagnostic products and surgical instruments and accessories. CVI and CSI each operate in highly competitive environments. The Company's products are medical devices subject to extensive regulation by the United States Food and Drug Administration (FDA) in the United States and other regulatory bodies abroad.
Company Website
SEC Reports
Industry: Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, ISRG
Traded in other countries:CP6.Germany
ยป More Articles for COO

Headlines

Articles On GuruFocus.com
Manning & Napier New Buys of Q1 Apr 19 2013 
The 3 Most-Recommended Healthcare Stocks Jan 02 2013 
The Cooper Companies: Not Eyeing It Yet Nov 27 2012 
How to Know What Rate of Return to Expect from Your Stocks: Part 2 Jul 03 2012 
Weekly CFO Sells Highlight: LOOP, ZAGG, MMC, LQDT, HAIN, SCVL, COO Sep 11 2011 
The 10 Dividend Stocks John Paulson Just Started Buying: HPQ, WY, FDO, SNI, SLG Jun 18 2011 
The Cooper Companies Inc. (COO) CEO - CSI Nicholas J Pichotta sells 6,602 Shares Jan 11 2011 
The Cooper Companies Inc. (COO) CEO - CSI Nicholas J Pichotta sells 2,650 Shares Dec 13 2010 
The Cooper Companies Inc. (COO) CEO - CSI Nicholas J Pichotta sells 9,684 Shares Apr 13 2010 
The Cooper Companies Inc. (COO) CEO - CSI Nicholas J Pichotta sells 15,348 Shares Oct 13 2009 

More From Our Partners
Omnicell Pinned at Neutral - Analyst Blog May 24 2013 - ZACKS

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial